Skip to main content

The midterms are taking shape. So are the problems – for both parties

(CNN) — After a major primary day this week in Michigan and other states, the battle for the House and Senate in the 2026 midterms has largely taken shape.

And increasingly … it’s complicated.

Elections are always messier the closer you get to November, with late developments that seem to come out of nowhere. There’s a reason the phrase “October Surprise” is a thing.

But that’s especially been the case in recent weeks. While Democrats’ uphill battle to win the Senate majority has become more fraught and uncertain, the GOP’s uphill battle to hold the House is running into its own very pronounced headaches.

So while the fundamentals have appeared pretty consistent for a while – Democrats have a clear advantage and chance to flip both chambers thanks to President Donald Trump’s historic unpopularity – the localized variables are starting to loom large.

The El-Sayed effect

First, let’s tackle that Senate majority math.

The biggest midterm news Tuesday – and arguably of the last few months – was left-wing candidate Abdul El-Sayed’s narrow victory in the Michigan Democratic primary.

The former public health official, whom the Democratic establishment desperately tried to help Rep. Haley Stevens defeat, is now in a position that the Bernie Sanders wing of the party has really never been in before: trying to win a crucial general election race in a battleground state.

Whether a candidate like El-Sayed can win a state like Michigan carries major implications for how big a force the Democratic Party’s left flank can be in the coming years.

But in the near term, the question is whether El-Sayed might jeopardize a race that Democrats probably need to win to have a shot at the Senate majority.

The jury is still very much out on that.

There is a school of thought that a more exciting and compelling candidate like him could turn out the base more than a candidate like Stevens. And even if El-Sayed does underperform, it’s possible the environment will simply be good enough for Democrats to pull him across the line. Recent history suggests that, absent major personal scandal, merely being extreme on issues generally costs candidate in the low-to-mid single digits.

But Republicans on Wednesday were gleefully pointing to things like El-Sayed’s ties to controversial left-wing streamer Hasan Piker and his sharp comments criticizing Israel, which could conceivably turn off significant portions of the Democratic coalition. They also suggestively cited his full name, clearly seeking to stoke anti-Muslim sentiment – which, while ugly and xenophobic, polling suggests could be effective.

What’s pretty evident: Stevens would have been the safer pair of hands in a good Democratic year.

The upshot is that the path through Michigan is probably more uncertain for Democrats now. And that sudden uncertainty has become a trend. In addition to El-Sayed’s nomination, both the Graham Platner fiasco in Maine and Pennsylvania Sen. John Fetterman’s flirtation with a party switch have become unwelcome variables potentially making Democrats’ difficult Senate math closer to unworkable.

Democrats need to flip four GOP seats to take the Senate majority and a tough map already means at least two of them would have to be in states where Trump won by double digits in 2024.

Having any of these variables go against them would mean they would increase that latter number to three or more.

On the plus side for Senate Democrats

All of that said, some of the recently introduced variables could still help Democrats by expanding the map.

Polls show them running very competitive in four of those red states – Alaska, Iowa, Ohio and Texas. They also got an intriguing nominee in deep-red Kansas on Tuesday in pastor Adam Hamilton.

And the exit of the Democratic nominee in South Dakota on Tuesday now makes it three states – along with Idaho and Nebraska – where the party’s nominee has stepped aside in favor of an independent candidates who might have better shot at beating Republicans.

The efficacy of that independent strategy remains in doubt. And these independent candidates tend to poll better than they actually perform, as I wrote in 2024. But these are states that are probably off the table otherwise – so even just making Republicans sweat a bit could be a win.

All of that said, the Democratic establishment would probably trade all of these longshot opportunities just to have Stevens as their nominee against Republican former Rep. Mike Rogers in November.

The House GOP’s growing personal mess

But even as the Senate has become more fraught for Democrats, the House is looking a lot messier for Republicans.

The personal scandals of Reps. Max Miller of Ohio, Chuck Edwards of North Carolina and Cory Mills of Florida increasingly threaten to not just put their marginally competitive seats in-play (Trump won all three districts by around 10 points in 2024), but also to cast a pall over the GOP’s efforts to hold the House.

Edwards bowed out of his reelection bid early Wednesday morning after a House Ethics Committee report found he made unwanted advances toward young female staffers. But GOP leaders have struggled mightily to figure out what to do about uglier allegations against Miller and Mills, both of whom have been accused of domestic abuse, among other misdeeds.

All three men have denied the most serious allegations they face.

The Miller situation is especially difficult given the ex-wife who accuses him of abuse is the daughter of GOP Sen. Bernie Moreno of Ohio, causing what was already an ugly family drama to spill even more into politics. This, and Miller’s increasingly bizarre personal response, has made it more difficult for GOP lawmakers to craft a cogent response.

While these are just a few seats, Republicans made great pains to try to help themselves lock down as many districts as possible by redistricting in a bunch of states this year. But in spite of those efforts, a bunch of other seats that would normally be safe have crept into the potentially competitive column – so much so that Democrats appear increasing favorites to win the House.

In fact, as the Cook Political Report’s Amy Walter noted this week, it’s all looking a lot like the Democratic wave of 2006.

There’s a historically unpopular president (back then, George W. Bush) and war in the Middle East (back then, Iraq), a “generic ballot” that favors Democrats by a similar and significant number (the mid-to-high single digits) and, now, a growing volume of lawmaker scandals that are testing GOP leaders’ ability to manage them (back then, Mark Foley and Don Sherwood).

Republicans would really prefer the outcome not be like 2006.

The-CNN-Wire
™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

What to know about Candida auris, a fungus contaminating healthcare spaces

(CNN) — Cases of Candida auris, a fungus found in healthcare facilities, are rising rapidly this year, the US Centers for Disease Control and Prevention says.As of July 25, 3,437 clinical cases in 27 states have been reported, CDC data shows. The agency recorded 4,290 clinical cases in all of last year.C. auris is primarily a concern for people who are hospitalized. The total number of clinical cases has been increasing since its detection in the US in 2016, the CDC says. The rate has slowed in recent years, but it still remains a “critical public health threat.”What is Candida auris, and how does it spread?Candida auris is a yeast, a specific type of fungus, that spreads through contact with contaminated objects and people, according to Dr. Graham Snyder, medical director of infection prevention and hospital epidemiology at University of Pittsburgh Medical Center.A common characteristic, Snyder said, is its ability to spread and remain in healthcare settings, including nursing facilities and hospitals, as it can resist certain cleaning products. It more seriously affects people who have underlying conditions.“We quickly learned that Candida auris is very good at sticking around in the environment — and that’s not true for all types of pathogens or germs that may be spread through the environment — so we pay extra special attention when we know somebody has Candida auris to making sure that we clean and disinfect the environment,” Snyder said.The first case of C. auris was detected in Japan in 2009; the first case in the United States was detected in 2016, according to the CDC. The agency characterizes C. auris as an “urgent threat,” as it is often multidrug-resistant, meaning certain strains can be resistant to all three classes of antifungal medications used to treat fungal infections.What happens when people get it?There are two ways people can have C. auris, said Dr. Scott Roberts, an associate professor of infection prevention at Yale University. The first, colonization, occurs when the fungi appear on a person’s skin, and it’s asymptomatic most of the time. The second, infection, happens when it enters the body through a break in the skin.C. auris can be detected via a swab of the armpit or groin area.“Most of the time, the infections occur through bloodstream infection. There’s some entry into the skin somewhere; maybe your immune system’s not as good as it should be. You can’t fight it off, and you lead to a big infection,” Roberts said.Although this year’s case count may sound alarming, Dr. Nitipong Permpalung, director of mycology research at Johns Hopkins University, noted that there has also been an increase in screening that differentiates between those who are colonized with C. auris and those who are infected, which could account for some of the rising numbers.“We need to understand that ‘OK, this is a positive screening test, and this is through clinical case, and go from there,’ but I understand the concern. But we need to get some more data, and we need to work on the research in this area to improve the care,” Permpalung said.Dr. Ilan Schwartz, an associate professor of medicine at Duke University, said the fungi can cause symptoms like fever, low blood pressure or a high heart rate, as well as a dangerous condition called sepsis, when it enters the bloodstream. Because it spreads more often in healthcare settings, Schwartz said, it primarily affects people who have other health conditions.Like many germs that can be potentially deadly “in the right circumstance,” Schwartz said, infections can become serious and can be deadly in vulnerable patients, such as those undergoing chemotherapy, recovering from surgery or taking antibiotics.“Generally, these are going to be in patients who are already hospitalized and who are being monitored, and so the healthcare team should be well aware already if patients are showing signs of a general infection, so I don’t think that it’s something individuals need to be vigilant about,” Schwartz said.Awareness at the forefrontRoberts said people who are hospitalized or living in other medical settings should watch for symptoms of sepsis, including fever, high heart rate and low blood pressure.The most important thing people can do if their doctor detects the fungi, Roberts said, is to notify those they live with or those who are around them in a care facility. In addition, focus on washing hands and not sharing medical equipment before it is disinfected.Although C. auris continues to spread, hospitals and nursing homes can screen people to identify the fungi and potentially isolate them as an infection prevention practice, Roberts said.“I just have low confidence every facility can do that, or even right now we don’t even know how big a problem it is because a lot of places are not testing for this or don’t have the lab capability to even identify it,” Roberts said.Roberts noted that once the fungi has colonized a person, treatment generally focuses on any symptoms that develop.“There’s unfortunately not much to do,” Roberts said. “It’s moreso just awareness that it is on the scan or that it is there in that room.”The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story